A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
Clinical trial NCT01228760 · COMPLETED
Trial details
- NCT number
- NCT01228760
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2013-02-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.